Healthcare remains an attractive sector for investors. Chronic disease management platform 91health has just raised $100 million from a number of blue-chip names.

Unfazed by critics over the legitimacy of its business model, Chinese healthcare crowdfunding site Shuidi raises $145 million from a star-studded list of investors.

The Beijing-based investment bank brings a tightly priced dollar-denominated bond as it starts building out its own international debt financing platform.

With fortuitous timing, China's first joint venture investment bank posted one of the year's best first-day share price performances in Hong Kong.

CICC has agreed to buy China Investment Securities for $2.5 billion, showing its determination to keep expanding amid tough competition in China's brokerage market.

The Chinese investment bank's final valuation range is a far cry from its initial billion-dollar ambitions.

China International Capital Corp has finally taken the first steps for its long-awaited $1 billion IPO in Hong Kong and could list as early as late September

Chinese investment bank looks to replenish its capital, sharpen its competitive strategy and strengthen its incentive scheme through a listing.

We explain how China's outstanding banks claimed FinanceAsia's awards, and why HSBC and Morgan Stanley were the top foreign players in the country.

Marshall Nicholson has resigned as co-head of international investment banking; the latest departure from the Chinese bank.